Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3844

This text appears to be a description of a medication named Rosuvastatin Calcium 5mg. The text includes details such as NDC numbers, lot numbers, expiration date, quantity (90 tablets), and manufacturer's information. There are warnings about keeping the medication out of reach of children and storing it at a controlled temperature. Patients are advised to consult their doctor for medical advice and to report any side effects to the FDA.*

This text provides statistical information on the hazard ratio (HR) of 0.56 with a 95% confidence interval of 0.46-0.69, indicating a significant difference with a p-value of less than 0.001. The cumulative incidence (%) for Rosuvastatin (RSV) is listed along with the number at risk for both RSV and Placebo groups.*

The provided text seems to be showing the results of a study comparing the effects of Rosuvastatin 20mg versus Placebo on various clinical endpoints in a group of 8901 patients. The Hazard Ratios (HRs) with 95% confidence intervals and p-values are reported for different endpoints such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. Significant reductions in the risk of events are seen in patients receiving Rosuvastatin 20mg compared to Placebo, especially for the primary endpoint and nonfatal MI. Additional information on event rates per 1000 patient-years and the definition of cardiovascular death is also provided in the text for reference.*

This is a list of common statin medications with their respective doses in milligrams: Rosuvastatin (10, 20, 40), Atorvastatin (10, 20, 40, 80), Simvastatin (10, 20, 40), Pravastatin (10, 20, 40). The text also mentions percent change from baseline in LDL-C levels. This information could be useful for comparing and evaluating the effectiveness of these different statins in managing cholesterol levels.*